Literature DB >> 18564459

Taking the next steps in the diagnosis of Alzheimer's disease: the use of biomarkers.

Steven T DeKosky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18564459     DOI： 10.1017/s1092852900017193

Source DB:  PubMed          Journal:  CNS Spectr        ISSN： 1092-8529            Impact factor:   3.790


× No keyword cloud information.
  3 in total

Review 1.  Biomarkers in translational research of Alzheimer's disease.

Authors:  Rawan Tarawneh; David M Holtzman
Journal:  Neuropharmacology       Date:  2010-04-13       Impact factor: 5.250

Review 2.  Critical issues for successful immunotherapy in Alzheimer's disease: development of biomarkers and methods for early detection and intervention.

Authors:  Rawan Tarawneh; David M Holtzman
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-04       Impact factor: 4.388

3.  Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment.

Authors:  I H G B Ramakers; F R J Verhey; P Scheltens; H Hampel; H Soininen; P Aalten; M Olde Rikkert; M M Verbeek; L Spiru; K Blennow; J Q Trojanowski; L M Shaw; P J Visser
Journal:  Psychol Med       Date:  2012-09-07       Impact factor: 7.723
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.